Comparison of Carto Versus Ensite 3D Electroanatomical Mapping Systems for Arrhythmias Ablations

NCT ID: NCT01651702

Last Updated: 2017-04-13

Basic Information

• Recruitment Status: WITHDRAWN
• Clinical Phase: NA
• Study Classification: INTERVENTIONAL
• Study Start Date: 2015-07-31
• Study Completion Date: 2016-10-31

Brief Summary

Three dimensional anatomical mapping is an established method facilitating ablation of cardiac arrhythmias. The most commonly used systems are CARTO® System (Biosense Webster, Inc., Diamond Bar, CA, USA) and EnSite NavX™ (St. Jude Medical, Inc., St. Paul, MN, USA). These two systems has been compared in only a few studies. Recent technical advances resulted in the development of new versions of both systems. To the best of the investigators knowledge no studies have been performed for direct comparison of the newer versions of these two systems. The aim of the study to compare two systems for the use in the ablation of complex arrhythmias.

Detailed Description

Background:

Three dimensional anatomical mapping is an established method facilitating ablation of cardiac arrhythmias. It is nowadays an excepted method especially for complex arrhythmias such as atrial fibrillation and ventricular tachycardia.

The most commonly used systems are CARTO® System (Biosense Webster, Inc., Diamond Bar, CA, USA) and EnSite NavX™ (St. Jude Medical, Inc., St. Paul, MN, USA). These mapping systems have helped to decrease procedural complexity, procedure time, and improve safety. The EnSite NavX system uses impedance measurements between the individual catheter electrodes and the patches placed on the patient's chest and abdomen. The CARTO system utilizes magnetic location technology to provide accurate visualization of the magnet sensor-equipped catheter tip.

These two systems has been compared in only a few studies. Different results have been found in simple ablations versus more complex ablation of atrial fibrillation. Recent technical advances resulted in the development of new versions of both systems. Carto Express version allows quicker mapping and reconstruction of heart cavities and great vessels geometry as compared to previous versions of Carto XP. EnSite Velocity system incorporates more precise catheter visualization, and allows quicker mapping as compared to previous version of EnSite.

To the best of the investigators knowledge no studies have been performed for direct comparison of the newer versions of these two systems.

Study design Prospective single-center non-randomized open label comparison study. Primary objective Comparison of Carto Express system vs. EnSite Velocity system for ablation of complex arrhythmias.

End points:

1. Procedure duration.

2. Fluoroscopy time

3. Procedure success -will be measured in terms of the 1-year recurrent arrhythmia rate Study population Patients planned for ablation of complex arrhythmia.

Conditions

Arrhythmias

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Carto

Patients in whom Carto system will be used

Group Type: ACTIVE_COMPARATOR

Carto

Intervention Type: DEVICE

Group of patients where Carto Express system will be used for electroanatomical mapping.

Ensite

Patients in whom Ensite system will be used

Group Type: ACTIVE_COMPARATOR

Ensite

Intervention Type: DEVICE

Group of patients where Ensite Velocity system will be used for electroanatomical mapping.

Interventions

Carto

Group of patients where Carto Express system will be used for electroanatomical mapping.

Intervention Type: DEVICE

Ensite

Group of patients where Ensite Velocity system will be used for electroanatomical mapping.

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

1. Age 18- 80.

2. Ability to sign informed consent.

3. History of one of the following arrhythmias requiring the use of 3D electroanatomical mapping:

• Symptomatic paroxysmal or persistent atrial fibrillation with failed treatment of at least two anti-arrhythmic drugs.
• Ischemic ventricular tachycardia necessitating ablation as per decision of electrophysiologist.
• Symptomatic atrial tachycardia after failed medical treatment.
• Symptomatic idiopathic ventricular tachycardia.

Exclusion Criteria

1. Unstable patients not allowing performing procedure more than 2 hours

2. Patients planned for one of the two systems compared for whatever reason Ex. procedure planned with NAVX system Array Balloon).

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 80 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Rabin Medical Center

OTHER

Sponsor Role: lead

Responsible Party

Gregory Golovchiner, MD

Principle Invistigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Gregory Golovchiner, MD

Role: PRINCIPAL_INVESTIGATOR

Rabin Medical Center

Other Identifiers

0067-12-RMC

Identifier Type: -

Identifier Source: org_study_id